Can a common acid pill prevent deadly bleeding in cirrhosis patients?
NCT ID NCT07248722
First seen Dec 10, 2025 · Last updated May 12, 2026 · Updated 21 times
Summary
This study looks at whether giving pantoprazole (a stomach acid reducer) after routine vein treatment can lower the risk of bleeding in people with cirrhosis and enlarged veins in the esophagus or stomach. About 208 adults will be randomly assigned to receive either pantoprazole or a placebo for a short time. The goal is to see if the drug reduces bleeding, side effects, and deaths within 6 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Gastroenterology, General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area)
Shenyang, Liaoning, 110840, China
Conditions
Explore the condition pages connected to this study.